Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage

Semin Thromb Hemost. 2021 Jun;47(4):442-446. doi: 10.1055/s-0041-1723754. Epub 2021 Feb 19.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Algorithms
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects*
  • Anticoagulants / therapeutic use
  • Blood Coagulation Tests
  • Blood Proteins / analysis
  • COVID-19 / blood*
  • COVID-19 / complications
  • COVID-19 / therapy
  • Clinical Protocols
  • Critical Care
  • Drug Monitoring / methods*
  • Enoxaparin / administration & dosage
  • Enoxaparin / adverse effects*
  • Enoxaparin / therapeutic use
  • Female
  • Hemorrhage / chemically induced
  • Hemorrhage / prevention & control*
  • Heparin / administration & dosage
  • Heparin / adverse effects*
  • Heparin / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Point-of-Care Testing
  • Postoperative Complications / epidemiology
  • Prospective Studies
  • Respiration, Artificial
  • Risk Factors
  • SARS-CoV-2*
  • Thrombelastography*
  • Thrombophilia / drug therapy*
  • Thrombophilia / etiology

Substances

  • Anticoagulants
  • Blood Proteins
  • Enoxaparin
  • Heparin